BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19655038)

  • 1. Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results.
    Brookhart MA; Schneeweiss S
    Int J Biostat; 2007; 3(1):Article 14. PubMed ID: 19655038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The missing cause approach to unmeasured confounding in pharmacoepidemiology.
    Abrahamowicz M; Bjerre LM; Beauchamp ME; LeLorier J; Burne R
    Stat Med; 2016 Mar; 35(7):1001-16. PubMed ID: 26932124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects?
    Brookhart MA; Rassen JA; Wang PS; Dormuth C; Mogun H; Schneeweiss S
    Med Care; 2007 Oct; 45(10 Supl 2):S116-22. PubMed ID: 17909369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable.
    Brookhart MA; Wang PS; Solomon DH; Schneeweiss S
    Epidemiology; 2006 May; 17(3):268-75. PubMed ID: 16617275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tutorial on the use of instrumental variables in pharmacoepidemiology.
    Ertefaie A; Small DS; Flory JH; Hennessy S
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):357-367. PubMed ID: 28239929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Instrumental variable analysis in the context of dichotomous outcome and exposure with a numerical experiment in pharmacoepidemiology.
    Koladjo BF; Escolano S; Tubert-Bitter P
    BMC Med Res Methodol; 2018 Jun; 18(1):61. PubMed ID: 29929467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instruments for causal inference: an epidemiologist's dream?
    Hernán MA; Robins JM
    Epidemiology; 2006 Jul; 17(4):360-72. PubMed ID: 16755261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Power calculator for instrumental variable analysis in pharmacoepidemiology.
    Walker VM; Davies NM; Windmeijer F; Burgess S; Martin RM
    Int J Epidemiol; 2017 Oct; 46(5):1627-1632. PubMed ID: 28575313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Instrumental variable methods for causal inference.
    Baiocchi M; Cheng J; Small DS
    Stat Med; 2014 Jun; 33(13):2297-340. PubMed ID: 24599889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The productivity of mental health care: an instrumental variable approach.
    Lu M
    J Ment Health Policy Econ; 1999 Jun; 2(2):59-71. PubMed ID: 11967410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication.
    Li Y; Lee Y; Wolfe RA; Morgenstern H; Zhang J; Port FK; Robinson BM
    Stat Med; 2015 Mar; 34(7):1150-68. PubMed ID: 25546152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long-acting beta2-agonist use and the risk of myocardial infarction.
    Uddin MJ; Groenwold RH; de Boer A; Afonso AS; Primatesta P; Becker C; Belitser SV; Hoes AW; Roes KC; Klungel OH
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():132-41. PubMed ID: 27038359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenging interpretation of instrumental variable estimates under monotonicity.
    Swanson SA; Hernán MA
    Int J Epidemiol; 2018 Aug; 47(4):1289-1297. PubMed ID: 28379526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing causal treatment effect estimation when using large observational datasets.
    John ER; Abrams KR; Brightling CE; Sheehan NA
    BMC Med Res Methodol; 2019 Nov; 19(1):207. PubMed ID: 31726969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating possible confounding by prescriber in comparative effectiveness research.
    Franklin JM; Schneeweiss S; Huybrechts KF; Glynn RJ
    Epidemiology; 2015 Mar; 26(2):238-41. PubMed ID: 25643103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of instrumental variables for endogenous treatment at the provider level.
    Konetzka RT; Yang F; Werner RM
    Health Econ; 2019 May; 28(5):710-716. PubMed ID: 30672042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
    Hogan JW; Lancaster T
    Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Instrumental variable estimation of truncated local average treatment effects.
    Choi BY
    PLoS One; 2021; 16(4):e0249642. PubMed ID: 33819276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A theoretical exploration of therapeutic monomania as a physician-based instrumental variable.
    Potter BJ; Dormuth C; Le Lorier J
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1(Suppl 1):45-52. PubMed ID: 31094048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness research considered methodological insights from simulation studies in physician's prescribing preference.
    Zhang L; Lewsey J; McAllister DA
    J Clin Epidemiol; 2022 Aug; 148():74-80. PubMed ID: 35447357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.